5 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Ptc Therapeutics, Inc. | 3 |
| Ptc Therapeutics, Inc. | 2 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18264183 | METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | Ptc Therapeutics, Inc. | MOU, LIYUAN | 1628 | Non-Final OA | Aug 03, 2023 |
| 18264187 | METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | Ptc Therapeutics, Inc. | HAVLIN, ROBERT H | 1626 | Non-Final OA | Aug 03, 2023 |
| 18256099 | INHIBITORS OF NLRP3 | Ptc Therapeutics, Inc. | SEITZ, ANTHONY JOSEPH | 1629 | Final Rejection | Jun 06, 2023 |
| 17923825 | DHODH INHIBITOR FOR THE TREATMENT OF COVID-19 | Ptc Therapeutics, Inc. | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Nov 07, 2022 |
| 17783941 | COMPOUNDS FOR TREATING FAMILIAL DYSAUTONOMIA | Ptc Therapeutics, Inc. | ANDERSON, REBECCA L | 1626 | Non-Final OA | Jun 09, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial